Another COVID-19 Win for Regeneron as FDA Okays Lower Dose of Antibody Cocktail
REGEN-COV's 1,200 mg dose is authorized to treat mild-to-moderate COVID-19 in adults and children 12 years and older who weigh 40 kilograms or more.
The Home of the Life Sciences Industry
Explore Latest News
CVR Holders Slap BMS with Lawsuit After Missed Liso-Cel Deadline
It didn’t take too long before a lawsuit was filed over Bristol Myers Squibb’s failure to meet a deadline for a $9 Contingent Value Rights agreement tied to the company’s merger with Celgene.
- Three Biopharma Companies Raise Millions in Separate Series A Financing Rounds
- Bayer Acquires Noria, PSMA Therapeutics to Expand Place in Prostate Cancer Space
- Bayer at ASCO: Vitrakvi Effective in TRK Fusion Cancers Regardless of Tumor Type
- Nanobiotix’s Radiotherapy Enhancer for Tumors Also Primes the Immune System
- Research Roundup: A Complete Human Genome Sequenced and More
Get personalized job alerts
Create a job alert and receive custom job recommendations straight to your inbox.
Employers
Post jobs on BioSpace and start building your talent pipeline today. Click the button to access our easy eCommerce site, which lets you purchase and post jobs in just a few clicks.